TiCEM - No Recurrence (USA)

66 year old lady with a previous history of lumpectomy in the right breast and no symptoms. You can see the inside tool. The views showing the architectural distortion due to the scar with no suspicious solutions. Let's move to the tunnel. On the thermostable you can see horrible architectural distortion just in the middle of the scar, with no fat inside the architectural distortion. And longest regulations. This image is suspicious. So. We can focus on this lesion. You see the longest stipulations. And not. Fat is not clearly detected inside. It's killing me. Say that this is a fun necrosis. That is why we perform a Tyson study. And it's very nice because you can see no enhancement of contrast. That is very good news, because this is only a scar and not a recurrence. So as all of you know, tomosynthesis is very sensitive to detect architecture, architectural distortions and speculations and some post surgical architectural distortions can mimic a recurrence. However, a morpho functional technique such as tisem can be better to evaluate a difficult scar.

Follow Up 2 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS . 12_FollowUp_2, PID3692 * 1/1/2022 F PID3692 Series Navigator INSIGHT_2D PID3692 8/1/2020 (Study date) INSIGHT_2D_RCC TRMLO TRCC Viewing Favorite Layouts US MR DYN MR.Dyna ... IN 2D MR.Empty ReportFlow BASIC Printing Tools Findings MR 5:54 PM Add Study TLCC C.US | C .... Clinical information 66-year-old female Lumpectomy in the right breast Asymptomatic Healthineers LCC RMLO RCC Slice 24 / 56 Slice 22 / 63 Slice 34 / 60 Slice 39 / 66 Slice thickhess: 1.00 mm LCC BASI Slice 42 / 66 Slice 35 / 67 Slice 36 / 69 LowEnergy Recombined Current Conclusion DBT is very sensitive for architectural distortions and spiculations. TiCEM can distinguish between a benign postoperative scar and a malignant recurrence. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. SIEMENS Hea